Portfolio
Four categories.One set of rules.
The materials in scope fall into four research categories. Each carries the same documentation obligations set out under quality: identity, analytical records, lot identification and defined handling.
This is a portfolio, not a catalogue. No prices, presentations, quantities or availability are published here.
Materials differ.So doesthe evidencebehind them.
Some materials in these categories are the subject of extensive published research. Others are early. The category a material sits in says nothing about the strength of evidence for it, and the framework does not treat them as equivalent.
What the words mean here
Five terms,used precisely.
- Research material
- A specific substance supplied under a stated identity, with records for the lot. It is not an authorised medicine.
- Research category
- A grouping used to organise the portfolio. It describes the subject area, not the status or strength of any material in it.
- Area of investigation
- A question researchers are studying. Naming it does not assert that any material addresses it.
- Evidence
- What published research supports for a specific material — which varies material by material, and is not implied by the category.
- Regulatory status and authorisation
- What a jurisdiction permits for that material, for a given use, by a given organisation. Determined by authorities, not by this framework.

Metabolic
Research around metabolic regulation, body composition and related endocrine questions.
Tirzepatide, Retatrutide, Semaglutide, Cagrilintide, MOTS-c, AOD9604, 5-amino-1MQ and related materials.

Recoveryand repair
Research around tissue repair, recovery after injury or surgery, and preservation of function.
BPC-157, TB500, GHK-Cu, KPV, LL37 and defined multi-component preparations.

Cellularand longevity
Research around cellular function, mitochondrial activity and long-term health questions.
NAD+, Epithalon, SS-31, FOXO4, L-Glutathione.

Neuro-endocrine
Research around endocrine signalling, immune modulation and neurological function.
Tesamorelin, Ipamorelin, Sermorelin, Thymosin Alpha-1, Semax, Selank, CJC-1295.
Every materialcarries thesame obligations.
Identity, analytical records for the lot, lot identification, supporting quality documentation and stated handling conditions apply across all four categories. A material that cannot meet them does not enter the framework.
How a material could be added
Four conditions,before anythingis offered.
- Product-specific information exists
- Identity, presentation and the information needed to describe the material are established before it is offered.
- Testing and documentation are defined
- The analytical scope for the material is set, and the records that would accompany each lot are known.
- Regulatory status is checked
- Import and use requirements in Ukraine are confirmed for that specific material, not for the category it sits in.
- Handling requirements are met
- Storage and transport conditions can be satisfied by the organisations expected to receive it.
Nothing on this page is a product listing, specification, availability statement or claim. Materials named here are research materials. Availability inside Ukraine would depend on local law, authorisation, import requirements, qualified oversight and product-specific evidence.
